DISRUPTED AUTOPHAGY IN ß-THALASSEMIA: A NEW LINK BETWEEN HEMICHROME CLEARANCE, MITOCHONDRIAL DYSFUNCTION AND INEFFECTIVE ERYTHROPOIESIS

EHA Library, Emanuele Tanzi, 4161265

ROXYSCAN ASSESSES PYRUVATE KINASE ACTIVATOR'S EFFECT ON OXIDATIVE STRESS SENSITIVITY IN ß-THALASSEMIA PATIENTS: AN ANCILLARY STUDY OF THE ENERGIZE/ ENERGIZE-T CLINICAL TRIALS

EHA Library, Eduard J. van Beers, 4161266

TNFα-NFKB DEREGULATION IS CRITICAL FOR CONTROLLING THE HSC POOL AND COMMITMENT IN BETA-THALASSEMIA

EHA Library, Giulia Chianella, 4161267

THE CDIN1-CODANIN-1 COMPLEX, DEFECTIVE IN CONGENITAL DYSERYTHROPOIETIC ANAEMIA TYPE I, IS A RNA NUCLEASE

EHA Library, Sanja Brolih, 4161272

RED BLOOD CELL AGE DISTRIBUTION AND METABOLIC FEATURES IN HEREDITARY SPHEROCYTOSIS, HEREDITARY XEROCYTOSIS AND CONGENITAL DYSERYTHROPOIETIC ANEMIA - BASELINE RESULTS OF EXPLORATORY ANALYSIS FROM THE SATISFY STUDY

EHA Library, Richard VAN WIJK, 4161273

DATA MANAGEMENT PRACTICES AND BENEFITS OF NATIONAL DATA MANAGEMENT COORDINATION IN RARE ANAEMIA DISORDERS REGISTRIES: RADEEP IN ITALY, A CASE STUDY

EHA Library, Roberta Trapanese, 4161276

IMPROVEMENT OF ANEMIA AND KIDNEY STATUS BY SEVUPARIN TREATMENT IN A MOUSE MODEL OF CHRONIC KIDNEY DISEASE

EHA Library, Michela Asperti, 4161279

DIFFERENTIAL ROLES FOR CELL CYCLE REGULATIONS BETWEEN TRANSFERRIN AND FERRITIN JUSTIFY THE DEVELOPMENT OF TRANSFERRIN RECEPTOR 1 BLOCKERS AS ANTINEOPLASTIC AGENTS OVER IRON CHELATORS

EHA Library, Ryo Yanagiya, 4161280

INTRAVENOUS IRON RELATED HYPOPHOSPHATEMIA AND POTENTIAL PREVENTING ROLE OF VITAMIN D SUPPLEMENTATION:„REAL LIFE” DATA FROM AN OUTPATIENTS CLINIC IN NORTH ITALY

EHA Library, Giovanni Inghilleri, 4161285

PREDICTIVE MACHINE LEARNING MODEL FOR SCREENING IRON DEFICIENCY WITHOUT ANEMIA USING AVAILABLE DATA FROM ELECTRONIC HEALTH RECORDS

EHA Library, Shelly Soffer, 4161287

NATIONWIDE STUDY OF SECONDARY CARE INFECTIONS AND INFECTION-RELATED DEATH IN PATIENTS WITH MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Ingrid Glimelius, 4161288

MVA-BASED GEO-CM04S1 VACCINE RESULTS IN IMPROVED CELLULAR IMMUNE RESPONSE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) COMPARED WITH MRNA-BASED VACCINE: INITIAL RESULTS OF A PHASE II RANDOMIZED STUDY

EHA Library, Alexey Danilov, 4161290

CLINICAL IMPACT OF METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS) OF PLASMA CELL-FREE DNA FOR THE DIAGNOSIS OF INFECTIOUS DISEASES IN PATIENTS WITH HEMATOLOGICAL DISORDERS

EHA Library, shanfeng hao, 4161291

LUNG MICROBIOTA ALTERATIONS IN HEMATOLOGICAL MALIGNANCY PATIENTS WITH PNEUMOCYSTIS PNEUMONIA

EHA Library, Giovangiacinto Paterno, 4161296

CLINICAL JOURNEY AND IMMUNOGLOBULIN-REPLACEMENT THERAPY IN PATIENTS WITH MULTIPLE MYELOMA AND SEVERE OR RECURRENT INFECTIONS

EHA Library, Elisabet Viayna, 4161297

IMMATURE PLATELET FRACTION AS A PREDICTOR OF PLATELET COUNT RECOVERY AND BLEEDING OCCURRENCE IN PATIENTS UNDERGOING INTENSIVE INDUCTION THERAPY FOR ACUTE LEUKEMIA.

EHA Library, Maha EL AMANI, 4161299

AUDIT ON THE ADHERENCE TO BRITISH SOCIETY OF HAEMATOLOGY GUIDELINES IN A TERTIARY CARE CENTRE

EHA Library, Silvia Lovato, 4161302

MONITORING THE HEMODYNAMIC QUALITY OF STORED BLOOD UNITS FOR IMPROVED TRANSFUSION OUTCOME, BY DETERMINING RED CELL MEMBRANE COMPONENTS

EHA Library, Saul Yedgar, 4161303

EFFECTIVENESS AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF ADULTS WITH NEWLY DIAGNOSED, PERSISTENT, OR CHRONIC IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS FROM THE PHASE 4 ADOPT STUDY

EHA Library, Waleed Ghanima, 4161305

UNRAVELING ITP PATHOGENESIS: A SINGLE-CELL AND IMMUNE REPERTOIRE ANALYSIS OF T AND B LYMPHOCYTES

EHA Library, Marianna Ciuffeda, 4161306

REAL-WORLD EFFICACY AND SAFETY OF FOSTAMATINIB FOR ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: ITALIAN MULTICENTER EXPERIENCE. FINAL RESULTS OF THE GIMEMA ITP1122 STUDY

EHA Library, Elise Lucchini, 4161307

INBORN ERRORS OF IMMUNITY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Nehal Joshi, 4161309

PREDICTING RESPONSE TO RITUXIMAB TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA BY IMMUNE PROFILING

EHA Library, Alicia Au, 4161310

IANALUMAB' S DUAL MECHANISM OF ACTION: TARGETING B CELLS THROUGH ENHANCED B-CELL DEPLETION AND BLOCKADE OF B CELL-ACTIVATING FACTOR RECEPTOR SIGNALING

EHA Library, Christoph Burkhart, 4161311

CLINICAL IMPACT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH SOLID TUMORS

EHA Library, Austin Nuschke, 4161312

REAL-WORLD TREATMENT PATTERNS & CLINICAL OUTCOMES IN THROMBOPOIETIN RECEPTOR AGONIST NAIVE PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH AVATROMBOPAG: INTERIM RESULTS FROM THE REAL-AVA 3.0 STUDY

EHA Library, Sandhya Panch, 4161313

CLINICAL CHARACTERISTIC OF ISOLATED THROMBOCYTOPENIA IN PATIENTS WITH BONE MARROW FAILURE-RELATED GERMLINE VARIANTS: A RETROSPECTIVE STUDY FROM A SINGLE CENTRE

EHA Library, Diijong Wu, 4161315

EFFECTIVENESS AND SAFETY OF AVATROMBOPAG FOR TREATMENT OF IMMUNE THROMBOCYTOPENIA IN OLDER PATIENTS AND THOSE WITH COMORBIDITIES OR PRIOR TPO-RA EXPOSURE: INTERIM RESULTS FROM THE PHASE 4 ADOPT STUDY

EHA Library, María Eva Mingot Castellano, 4161316

EFFECT OF EFGARTIGIMOD IV ON IMMATURE PLATELET COUNT FRACTION IN PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Francesco Zaja, 4161317

RESPONSE TO AVATROMBOPAG AMONG PATIENTS WITH CHRONIC AND ACUTE/PERSISTENT PRIMARY IMMUNE THROMBOCYTOPENIA: THE REAL-AVA 2.0 REAL-WORLD STUDY

EHA Library, M. Levy, 4161318

RNA SEQUENCING CONFIRMS PATHOGENICITY OF A NOVEL HOMOZYGOUS INTRON VARIANT IN NBEAL2 CAUSING GREY PLATELET SYNDROME

EHA Library, Eva Birgitte Leinoe, 4161319

RIPERTAMAB, A NOVEL ANTI-CD20 MONOCLONAL ANTIBODY FOR TREATING REFRACTORY/RELAPSED IMMUNE THROMBOCYTOPENIA:A PROSPECTIVE, MULTICENTER CLINICAL STUDY

EHA Library, Yimei Feng, 4161320

EFFICACY AND SAFETY OF HETROMBOPAG FOR PARP INHIBITOR-INDUCED THROMBOCYTOPENIA: A PHASE II OPEN-LABEL, PROSPECTIVE TRIAL

EHA Library, Qinhao GUO, 4161321

SIROLIMUS TREATMENT FOR ITP WITH ABNORMAL ANTINUCLEAR ANTIBODY SPECTRUM CAN ACHIEVE LONG-LASTING EFFICACY

EHA Library, Yimei Feng, 4161322

EVALUATION OF EFFICACY AND SAFETY OF AVATROMBOPAG IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA BASED ON DISEASE DURATION: RESULTS FROM THE AVATROMBOPAG PHASE 3-B PEDIATRIC TRIAL

EHA Library, Rachael Grace, 4161324

THE ROLE OF SYMPATHETIC NERVE REGULATION IN MEGAKARYOCYTE FUNCTION AND PLATELET PRODUCTION IN IMMUNE THROMBOCYTOPENIA

EHA Library, Menglin Li, 4161325

IL-1ß INDUCE CAR-T-ASSOCIATED COAGULOPATHY VIA THE HSP90/KALLIKREIN/UPA PATHWAY

EHA Library, Heng Mei, 4161326

SUSCEPTIBILITY TO BLEEDING IN ITP IS NOT INCREASED IN ELDERLY PATIENTS: EVIDENCE FROM THE UK ITP REGISTRY

EHA Library, Frederick Chen, 4161327

ARVENACOGENE SANPARVOVEC, A NOVEL OPTION FOR HEMOPHILIA B GENE THERAPY: FIRST-IN-HUMAN FINDINGS

EHA Library, Nadezhda Zozulya, 4161329

AN OBSERVATIONAL STUDY TO DESCRIBE THE IMPACT AND BURDEN OF NON-SEVERE HEMOPHILIA A FROM THE PATIENT'S PERSPECTIVE IN SPAIN: LEMON STUDY

EHA Library, Manuel R. Lopez, 4161330

EFFICACY OF IANALUMAB IN A MOUSE MODEL OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

EHA Library, Karina Yazdanbakhsh, 4161331

FACTORS INFLUENCING THE CHOICE OF ROMIPLOSTIM OR ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA: INSIGHTS FROM A REAL-WORLD EUROPEAN COHORT

EHA Library, Maria Lozano, 4161333

ANAEMIA, IRON DEFICIENCY, AND HAEMOLYSIS IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Justin Oosterlee, 4161336

ONLINE MEDICAL EDUCATION RESULTS IN PRACTICE CHANGES AND IDENTIFIES BARRIERS IN CONSIDERING PROPHYLAXIS FOR PATIENTS WITH MODERATE HEMOPHILIA A WITH A SEVERE BLEEDING PHENOTYPE

EHA Library, S Christy Rohani-Montez, 4161337

CLINICAL AND GENETIC ANALYSIS OF CONGENITAL FIBRINOGEN DISORDERS IN CHINESE PATIENTS: IDENTIFICATION OF SEVEN NOVEL MUTATIONS

EHA Library, Yuxiu Chen, 4161339

PROGNOSTIC ACCURACY OF THE DIFFERENT SCORING SYSTEMS FOR ASSESSING MORTALITY IN SEPSIS

EHA Library, Gülçin Çelebi, 4161340

EFFECTS OF THROMBOPOIETIN AND THROMBOPOIETIN RECEPTOR AGONISTS ON PLATELET ACTIVATION AND THROMBOSIS

EHA Library, Fan Zhou, 4161342

IDENTIFICATION OF NEW MOLECULAR MECHANISMS OF ANTITHROMBIN DEFICIENCY: RESULTS FROM A POLISH COHORT

EHA Library, Anetta Undas, 4161345

EASIX, A NEW TOOL TO PREDICT RESPONSE AND REFRACTORINESS IN IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA?

EHA Library, Maria Queralt Salas, 4161346

PHENOTYPING THE INTRINSIC THROMBIN GENERATION IN PLASMA SAMPLES CONTAINING HEPARIN: THE CASE OF TINZAPARIN NEUTRALIZATION.

EHA Library, Emilie Chalayer, 4161347

RELATIONSHIP BETWEEN PODOPLANIN EXPRESSION IN COVID-19 INFECTED PATIENTS AND THE INCIDENCE OF THROMBOTIC EVENTS

EHA Library, Ibtesam Khalifa, 4161350

SIMILAR EFFICACY AND SAFETY OF PLASMA-DERIVED PROTEIN C CONCENTRATE BETWEEN ASIAN AND NON-ASIAN PATIENTS WITH SEVERE CONGENITAL PROTEIN C DEFICIENCY

EHA Library, Zhaoyang Li, 4161351

FEASIBILITY OF IV EPOPROSTENOL FOR ACUTE LIMB ISCHEMIA IN ANTIPHOSPHOLIPID SYNDROME: A COMPARATIVE REVIEW OF SAFETY OUTCOMES

EHA Library, George Mason, 4161352

HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM BURDEN IN PRE-FIBROTIC AND OVERT MYELOFIBROSIS COMPARED TO THE GENERAL POPULATION AND PHYSICIAN PERCEPTIONS: RESULTS FROM THE GIMEMA-PROPHECY STUDY

EHA Library, Giovanni Caocci, 4161354

PATIENT-PHYSICIAN COMMUNICATION REGARDING TKI-RELATED ADVERSE EVENTS AND THEIR IMPACT ON QUALITY OF LIFE IN CML - INSIGHTS FROM PATIENT AND PHYSICIAN SURVEYS IN THE US

EHA Library, David Wei, 4161357

EVALUATION OF SAFETY AND GUIDELINE COMPLIANCE IN HOME RED BLOOD CELL TRANSFUSIONS: A 10-YEAR RETROSPECTIVE STUDY IN SUBURBAN TOKYO

EHA Library, Takeshi Hagino, 4161358

LONG TERM SURVIVORSHIP AFTER ALLOGENEIC HSCT: COGNITIVE IMPAIRMENT AND PSYCHOMETRIC INDICATORS AS PREDICTIVE FACTORS FOR RETURN TO WORK (NEW INSIGHTS IN THE SOPRALLO PROJECT)

EHA Library, Yana Stepanishyna, 4161359

QUALITY OF LIFE AND WORK IMPACTS AMONG CAREGIVERS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) - A CAREGIVER SURVEY IN THE US

EHA Library, David Wei, 4161360

CHIP-RELATED MUTATIONS AS PREDICTORS OF CARDIOVASCULAR AND CEREBROVASCULAR EVENTS IN MYELOID NEOPLASMS: A RETROSPECTIVE COHORT ANALYSIS

EHA Library, Yao Wang, 4161361

INVESTIGATING THE KEY PREDICTORS OF QUALITY OF LIFE IN LEUKAEMIA PATIENTS: ANALYSIS OF GLOBAL STUDY DATA USING GRADIENT BOOSTED DECISION TREES.

EHA Library, Sam Salek, 4161364

HEALTH-RELATED QUALITY OF LIFE AND PREFERENCE FOR TREATMENT MODALITIES OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS OF A REAL-WORLD STUDY

EHA Library, Alexander Röth, 4161365

A NEW METHOD FOR ANALYZING BONE MARROW CELL POPULATIONS BY SPECTRAL FLOW CYTOMETRY

EHA Library, Laura BRAUD, 4161268

INCREASED ALL-CAUSE MORTALITY AMONG PATIENTS DIAGNOSED WITH WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA COMPARED TO THE GENERAL POPULATION: A NATIONWIDE REGISTER STUDY IN SWEDEN

EHA Library, Christian Kjellander, 4161269

IMPACT OF RILZABRUTINIB ON BIOMARKERS OF INFLAMMATION AND COMPLEMENT FACTORS IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): RESULTS FROM THE PHASE 2 STUDY

EHA Library, Nichola Cooper, 4161271

TARGETING STAT1 AS A POTENTIAL THERAPEUTIC APPROACH FOR AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Linhui Hu, 4161274

PIEZO1 GAIN-OF-FUNCTION DRIVES GLYCOLYTIC IMBALANCE IN LATE-STAGE ERYTHROPOIESIS: THE POTENTIAL OF MITAPIVAT THERAPY IN DEHYDRATED HEREDITARY STOMATOCYTOSIS

EHA Library, Barbara Eleni Rosato, 4161275

ELLAGIC ACID ALLEVIATES IRON OVERLOAD-INDUCED LIVER DAMAGE BY MITIGATING FERROPTOSIS THROUGH MODULATION OF THE TGFß/SMAD SIGNALING PATHWAY

EHA Library, Hangjie Fu, 4161278

SINGLE- AND MULTIPLE-ASCENDING DOSES OF DISC-3405, A RECOMBINANT HUMANIZED ANTIBODY TARGETING TMPRSS6, INCREASED HEPCIDIN AND REDUCED IRON AND HEMATOCRIT IN HEALTHY VOLUNTEERS

EHA Library, Marcus Carden, 4161281

STRIKE THE IRON WHILE IT'S LOW: REDEFINING IRON DEFICIENCY IN WOMEN

EHA Library, Ayesha Shameem, 4161282

REAL-WORLD SAFETY PROFILE OF DEFERIPRONE TWICE-A-DAY (DFP BID) FOR TRANSFUSIONAL IRON OVERLOAD IN PATIENTS IN THE UNITED STATES WITH THALASSEMIA, SICKLE CELL DISEASE (SCD) OR OTHER ANEMIAS

EHA Library, Sujit Sheth, 4161283

RESULTS FROM THE HELIOS STUDY: A PHASE 2, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA

EHA Library, Melanie Chin, 4161284

FERRITIN INDEX OF SOLUBLE TRANSFERRIN RECEPTOR AND IRON STATUS BIOMARKERS FOR IRON DEFICIENCY ANEMIA DIAGNOSIS - COMPARISON AND CORRELATION WITH IRON THERAPY RESPONSE

EHA Library, Nina Petkova, 4161286

CMV VIREMIA IN NON-TRANSPLANT ADOLESCENT AND ADULT PATIENTS TREATED WITH ACUTE LYMPHOBLASTIC LEUKEMIA PROTOCOLS

EHA Library, Hamsa Murli, 4161289

EPIDEMIOLOGY AND SEVERITY OF PARVOVIRUS B19 INFECTION IN RED BLOOD CELL DISORDERS DURING THE EPIDEMIC SEASON 2023-2024: A NATIONWIDE REPORTFROM ITALIAN AIEOP CENTRES

EHA Library, Maria Paola Boaro, 4161292

WORLDWIDE EXPERIENCE OF CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION: A MULTINATIONAL RETROSPECTIVE COHORT STUDY

EHA Library, chunrui li, 4161293

AGGRESSIVE CLINICAL FEATURES AND POOR OUTCOME MAY ASSOCIATE WITH DECREASED IMMUNE FUNCTION IN HIV POSITIVE HL IN THE CART ERA: A MULTICENTER STUDY FROM CHINA

EHA Library, Chaoyu Wang, 4161294

CLINICAL CHARACTERISTICS AND OUTCOMES OF SEPSIS-INDUCED COAGULOPATHY AND DISSEMINATED INTRAVASCULAR COAGULATION FOLLOWING ALLO-HSCT

EHA Library, Qiu-sha Huang, 4161295

MATCHED COHORT STUDY COMPARING THE IMPACT OF RSV, INFLUENZA, AND SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES

EHA Library, Francesco MARCHESI, 4161298

IMPACT OF IMMUNE PLATELET REFRACTORINESS IN THE TREATMENT COURSE OF ACUTE LEUKEMIA ADULT PATIENTS AT A TERTIARY CENTER

EHA Library, Anna Arrufat Bel, 4161300

UPFRONT TRANSFUSION OF NON-LEUKOREDUCED LOW-TITER GROUP O+ WHOLE BLOOD IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED 30-DAY SURVIVAL IN SEVERELY INJURED CIVILIAN TRAUMA PATIENTS

EHA Library, Eldad Dann, 4161301

TO TRANSFUSE OR NOT TO TRANSFUSE A BABY: THAT IS THE QUESTION!

EHA Library, Filipa Fonseca-Dias, 4161304

EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF PEDIATRIC IMMUNE THROMBOCYTOPENIA IN THE OPEN-LABEL EXTENSION OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

EHA Library, Rachael Grace, 4161308

CLINICAL FACTORS ASSOCIATED WITH RESPONSE TO RILZABRUTINIB, A BRUTON TYROSINE KINASE (BTK) INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) TREATED IN THE PHASE 3 LUNA3 STUDY

EHA Library, David J. Kuter, 4161314

CHANGES IN CYTOKINE PROFILES AFTER TREATMENT WITH RITUXIMAB AND THROMBOPOIETIN RECEPTOR AGONISTS IN IMMUNE THROMBOCYTOPENIA

EHA Library, Anbjørg Rangberg, 4161323

PHASE I AND III STUDY RESULTS OF RECOMBINANT HUMAN COAGULATION FACTOR VIIA (TQG203):PHARMACOKINETICS/PHARMACODYNAMICS,EFFICACY AND SAFETY OF TQG203 IN HEMOPHILIA PATIENTS WITH INHIBITORS

EHA Library, Lei Zhang, 4161328

THE MAASTRICHT BLEEDING COHORT: PHENOTYPIC AND GENOTYPIC INSIGHTS INTO GENDERED PATTERNS OF BLEEDING DISORDERS

EHA Library, Nienke Meskes, 4161332

ALK1-BMPRII RECEPTOR AGONISM TREATS VASCULAR PATHOLOGY IN HEREDITARY HEMORRHAGIC TELANGIECTASIA MODELS

EHA Library, Melissa Geddie, 4161334

ASSESSMENT OF NOVEL POINT-OF-CARE WHOLE BLOOD COAGULATION ASSAY TO EVALUATE COAGULATION RESPONSE TO BIAB FVIIIA MIMETIC AND FVIII THERAPY

EHA Library, Christina Higgins, 4161335

THE PRESENCE OF HEMORRHAGIC SYNDROME IN ACUTE MYELOID LEUKEMIA PATIENTS WITH THROMBOCYTOPENIA

EHA Library, Vira Barilka, 4161338

A RISK ASSESSMENT MODEL THAT INCORPORATES THROMBOINFLAMMATION BIOMARKERS ENHANCES THE ABILITY TO PREDICT EARLY DISEASE PROGRESSION IN ADVANCED-STAGE NON-SMALL CELL LUNG CANCER PATIENTS

EHA Library, Patricia Gomez Rosas, 4161341

THE UTILITY OF URINE QUALITATIVE ASSESSMENT FOR DIRECT ORAL ANTICOAGULANTS IN ROUTINE CLINICAL PRACTICE

EHA Library, Francesca Schieppati, 4161343

HIGH RISK OF RECURRENT VENOUS THROMBOEMBOLISM WITHIN TWO YEARS OF THE FIRST EPISODE IN PATIENTS WITH LYMPHOMA DESPITE ANTICOAGULATION

EHA Library, Ingrid Lundahl, 4161344

FACTORS RELATED TO ADHERENCE TO DIRECT ORAL ANTICOAGULANTS: IMPACT OF CLINICAL OUTPATIENT FOLLOW-UP

EHA Library, Maricel Subira, 4161348

EFFECT OF PROC GENE VARIANTS ON VENOUS THROMBOSIS: A RETROSPECTIVE CASE-CONTROL STUDY IN TAIWANESE POPULATION

EHA Library, Chi-yen Chen, 4161349

MULTICENTER MIXED METHODS RANDOMIZED CONTROLLED TRIAL OF FEASIBILITY AND EFFICACY OF A SUPERVISED PHYSICAL ACTIVITY INTERVENTION IN MYELOPROLIFERATIVE NEOPLASMS: THE MPN-FIT TRIAL

EHA Library, Marie Ouellet, 4161353

HEALTH-RELATED QUALITY OF LIFE BENEFITS OF FRONTLINE PONATINIB PLUS BLINATUMOMAB IN ADULT PATIENTS WITH PH+ ACUTE LYMPHOBLASTIC LEUKEMIA. PRELIMINARY ANALYSIS OF THE GIMEMA ALL2820 TRIAL

EHA Library, Laura Cannella, 4161355

PATIENT REPORTED OUTCOMES FROM BRUIN CLL-321: A RANDOMIZED PHASE 3 TRIAL COMPARING PIRTOBRUTINIB TO IDELALISIB/RITUXIMAB OR BENDAMUSTINE/RITUXIMAB IN COVALENT BTKI PRETREATED CLL/SLL

EHA Library, Paolo Ghia, 4161356

A PATIENT-REPORTED OUTCOME MEASURE (PROM) TO CAPTURE PATIENTS' EXPERIENCES WITH IMMUNO-ONCOLOGY THERAPY (IO)-INDUCED CYTOKINE RELEASE SYNDROME (CRS): THE IO-INDUCED CRS PATIENT DIARY

EHA Library, Sophie Van Tomme, 4161362

MYELOMA PATIENTS' ATTITUDES AND PERCEIVED BURDEN TOWARDS TREATMENT ROUTES AND LOCATIONS: INSIGHTS FROM A EUROPEAN SURVEY

EHA Library, Eilidh Duncan, 4161363

PATIENT-REPORTED OUTCOMES FROM A PHASE 3, RANDOMIZED TRIAL EVALUATING THE COMBINATION OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Christopher Hartford, 4161366